ProfileGDS5678 / 1459654_at
TitleAnti-VEGF and Anti-Notch treatment effect on U87 glioblastoma xenograft tumors [Mouse430_2]
OrganismMus musculus


control bevacizumab dibenzazepine GSM967852 GSM967853 GSM967854 GSM967855 GSM967856 GSM967862 GSM967863 GSM967864 GSM967865 GSM967857 GSM967858 GSM967859 GSM967860 GSM967861 8% 8% 8% 8% 8% 8% 8% 8% 8% 8% 8% 8% 8% 8% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM967852U87-EV human glioblastoma xenograft - Control 12.211688
GSM967853U87-EV human glioblastoma xenograft - Control 22.193938
GSM967854U87-EV human glioblastoma xenograft - Control 32.193848
GSM967855U87-EV human glioblastoma xenograft - Control 42.138678
GSM967856U87-EV human glioblastoma xenograft - Control 52.144768
GSM967862U87-EV human glioblastoma xenograft - Bevacizumab treated 12.253678
GSM967863U87-EV human glioblastoma xenograft - Bevacizumab treated 22.214818
GSM967864U87-EV human glioblastoma xenograft - Bevacizumab treated 32.170488
GSM967865U87-EV human glioblastoma xenograft - Bevacizumab treated 42.168148
GSM967857U87-EV human glioblastoma xenograft - dibenzazepine treated 12.184818
GSM967858U87-EV human glioblastoma xenograft - dibenzazepine treated 22.175918
GSM967859U87-EV human glioblastoma xenograft - dibenzazepine treated 32.165768
GSM967860U87-EV human glioblastoma xenograft - dibenzazepine treated 42.188088
GSM967861U87-EV human glioblastoma xenograft - dibenzazepine treated 52.183498